HK
Harsimran Kaur
About Harsimran Kaur
Data last updated:
Harsimran Kaur is a Director at Esemite Lifesciences Private Limited (since 2024) and Additional Director at Candor Lifesciences Limited (since 2025). The companies operate in Food And Beverages and Pharma. The largest current company by reported revenue is Esemite Lifesciences Private Limited at ₹2.56 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Jan 2024 | 2022 | ₹2.56 Cr (FY 2025) | Active | |
| Additional Director | 01 Nov 2025 | 2021 | Active |
Board colleagues of Harsimran Kaur
| Name | DIN | Company | Designation |
|---|---|---|---|
| Navreet Kaur | 09368565 | Esemite Lifesciences Private Limited , Candor Lifesciences Limited | Director |
| Amarjit Singh | 00509040 | Candor Lifesciences Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Harsimran Kaur
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Harsimran Kaur
Harsimran Kaur currently holds 2 directorships: Esemite Lifesciences Private Limited (Director, since 22 Jan 2024, revenue ₹2.56 Cr (FY 2025)); Candor Lifesciences Limited (Additional Director, since 01 Nov 2025).
Harsimran Kaur was first appointed on 22 Jan 2024 as Director at Esemite Lifesciences Private Limited. The most recent appointment on record is 01 Nov 2025 at Candor Lifesciences Limited.
The current boards of Harsimran Kaur's companies include Navreet Kaur (Esemite Lifesciences Private Limited), Amarjit Singh (Candor Lifesciences Limited).